These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19053772)

  • 41. Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorption.
    Sanders JM; Song Y; Chan JM; Zhang Y; Jennings S; Kosztowski T; Odeh S; Flessner R; Schwerdtfeger C; Kotsikorou E; Meints GA; Gómez AO; González-Pacanowska D; Raker AM; Wang H; van Beek ER; Papapoulos SE; Morita CT; Oldfield E
    J Med Chem; 2005 Apr; 48(8):2957-63. PubMed ID: 15828834
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates: a crystallographic and computational investigation.
    K-M Chen C; Hudock MP; Zhang Y; Guo RT; Cao R; No JH; Liang PH; Ko TP; Chang TH; Chang SC; Song Y; Axelson J; Kumar A; Wang AH; Oldfield E
    J Med Chem; 2008 Sep; 51(18):5594-607. PubMed ID: 18800762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent advances in understanding the mechanism of action of bisphosphonates.
    Coxon FP; Thompson K; Rogers MJ
    Curr Opin Pharmacol; 2006 Jun; 6(3):307-12. PubMed ID: 16650801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiparasitic Activity of Sulfur- and Fluorine-Containing Bisphosphonates against Trypanosomatids and Apicomplexan Parasites.
    Galaka T; Ferrer Casal M; Storey M; Li C; Chao MN; Szajnman SH; Docampo R; Moreno SN; Rodriguez JB
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28054995
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enthalpy versus entropy-driven binding of bisphosphonates to farnesyl diphosphate synthase.
    Yin F; Cao R; Goddard A; Zhang Y; Oldfield E
    J Am Chem Soc; 2006 Mar; 128(11):3524-5. PubMed ID: 16536518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. QSAR Models for Nitrogen Containing Monophosphonate and Bisphosphonate Derivatives as Human Farnesyl Pyrophosphate Synthase Inhibitors Based on Monte Carlo Method.
    Kumar P; Kumar A; Sindhu J; Lal S
    Drug Res (Stuttg); 2019 Mar; 69(3):159-167. PubMed ID: 30036888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bisphosphonates derived from fatty acids are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase.
    Szajnman SH; Montalvetti A; Wang Y; Docampo R; Rodriguez JB
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3231-5. PubMed ID: 12951099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disruption of insect isoprenoid biosynthesis with pyridinium bisphosphonates.
    Sen SE; Wood L; Jacob R; Xhambazi A; Pease B; Jones A; Horsfield T; Lin A; Cusson M
    Insect Biochem Mol Biol; 2015 Aug; 63():113-23. PubMed ID: 26073627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates and diphosphates: a potential route to new bone antiresorption and antiparasitic agents.
    Szabo CM; Matsumura Y; Fukura S; Martin MB; Sanders JM; Sengupta S; Cieslak JA; Loftus TC; Lea CR; Lee HJ; Koohang A; Coates RM; Sagami H; Oldfield E
    J Med Chem; 2002 May; 45(11):2185-96. PubMed ID: 12014956
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergistic Activity between Statins and Bisphosphonates against Acute Experimental Toxoplasmosis.
    Li ZH; Li C; Szajnman SH; Rodriguez JB; Moreno SNJ
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 3-D QSAR investigations of the inhibition of Leishmania major farnesyl pyrophosphate synthase by bisphosphonates.
    Sanders JM; Gómez AO; Mao J; Meints GA; Van Brussel EM; Burzynska A; Kafarski P; González-Pacanowska D; Oldfield E
    J Med Chem; 2003 Nov; 46(24):5171-83. PubMed ID: 14613320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure and mechanism of the farnesyl diphosphate synthase from Trypanosoma cruzi: implications for drug design.
    Gabelli SB; McLellan JS; Montalvetti A; Oldfield E; Docampo R; Amzel LM
    Proteins; 2006 Jan; 62(1):80-8. PubMed ID: 16288456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases.
    De Schutter JW; Park J; Leung CY; Gormley P; Lin YS; Hu Z; Berghuis AM; Poirier J; Tsantrizos YS
    J Med Chem; 2014 Jul; 57(13):5764-76. PubMed ID: 24911527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bisphosphonate inhibitors of Toxoplasma gondi growth: in vitro, QSAR, and in vivo investigations.
    Ling Y; Sahota G; Odeh S; Chan JM; Araujo FG; Moreno SN; Oldfield E
    J Med Chem; 2005 May; 48(9):3130-40. PubMed ID: 15857119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity of bisphosphonates against Trypanosoma brucei rhodesiense.
    Martin MB; Sanders JM; Kendrick H; de Luca-Fradley K; Lewis JC; Grimley JS; Van Brussel EM; Olsen JR; Meints GA; Burzynska A; Kafarski P; Croft SL; Oldfield E
    J Med Chem; 2002 Jul; 45(14):2904-14. PubMed ID: 12086478
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An investigation of bisphosphonate inhibition of a vacuolar proton-pumping pyrophosphatase.
    Szabo CM; Oldfield E
    Biochem Biophys Res Commun; 2001 Sep; 287(2):468-73. PubMed ID: 11554752
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bisphosphonate inhibitors of squalene synthase protect cells against cholesterol-dependent cytolysins.
    Pospiech M; Owens SE; Miller DJ; Austin-Muttitt K; Mullins JGL; Cronin JG; Allemann RK; Sheldon IM
    FASEB J; 2021 Jun; 35(6):e21640. PubMed ID: 33991130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii.
    Yardley V; Khan AA; Martin MB; Slifer TR; Araujo FG; Moreno SN; Docampo R; Croft SL; Oldfield E
    Antimicrob Agents Chemother; 2002 Mar; 46(3):929-31. PubMed ID: 11850291
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phosphonosulfonates are potent, selective inhibitors of dehydrosqualene synthase and staphyloxanthin biosynthesis in Staphylococcus aureus.
    Song Y; Lin FY; Yin F; Hensler M; Rodrígues Poveda CA; Mukkamala D; Cao R; Wang H; Morita CT; González Pacanowska D; Nizet V; Oldfield E
    J Med Chem; 2009 Feb; 52(4):976-88. PubMed ID: 19191557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New insights into human farnesyl pyrophosphate synthase inhibition by second-generation bisphosphonate drugs.
    Fernández D; Ramis R; Ortega-Castro J; Casasnovas R; Vilanova B; Frau J
    J Comput Aided Mol Des; 2017 Jul; 31(7):675-688. PubMed ID: 28631130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.